% Expired Patents = 75.0

CIPO Patents = 1

EPO Patents = 5

Forward Citations = 4

Loading Chart...

6 inventors (with patents filed for the assignee):

Bo Åkerström (3 out of 5 patents)

Stefan Hansson (3 out of 4 patents)

Magnus Gram (2 out of 2 patents)

4. Lena Wester Rosenlöf (1 out of 2 patents)

5. Martin Lennarth Olsson (1 out of 1 patent)

6. Bo Åkerstrom (1 out of 1 patent)

7. Bo Akerström (0 patent)

8. Bo Akerstroem (0 patent)

9. Lena ROSENLÖF (0 patent)

10. Bo Åkerström (0 patent)

4 patents: Sort by Forward Citations

1. 10359406 - Diagnosis and treatment of preeclampsia (2019-07-23),

2. 10350268 - Medical use of the radical scavenger and antioxidant alpha-1-microglobulin (2019-07-16),

3. 10226507 - Alpha-1-microglobulin for use in the treatment of mitochondria-related diseases (2019-03-12),

4. 8568999 - Diagnosis and treatment of preeclampsia (2013-10-29),

A1M Pharma AB is a biopharmaceutical company that develops therapeutic proteins for the treatment of severe kidney damage and related conditions. With a focus on improving patient outcomes and addressing unmet medical needs, A1M Pharma aims to bring novel therapies to market that have the potential to make a significant impact on human health.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

4 Patents

#84 in Lund

#1,302 in Sweden

Lund, Sweden

A1m Pharma Ab

Forward Citations = 4

6 inventors:

Bo Åkerström (3 out of 5 patents)

Stefan Hansson (3 out of 4 patents)

Magnus Gram (2 out of 2 patents)

4. Lena Wester Rosenlöf (1 out of 2 patents)

5. Martin Lennarth Olsson (1 out of 1 patent)

Please report any incorrect information to [email protected]

1 patent (CIPO):

Please report any incorrect information to [email protected]

5 patents (EPO):

Please report any incorrect information to [email protected]